The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies

Berlanga, Pablo; Pierron, Gaelle; Lacroix, Ludovic; Chicard, Mathieu; Adam de Beaumais, Tiphaine; Marchais, Antonin; Soriano Fernández, Aroa; Hladun Alvaro, Raquel

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Berlanga, Pablo
dc.contributor.author	Pierron, Gaelle
dc.contributor.author	Lacroix, Ludovic
dc.contributor.author	Chicard, Mathieu
dc.contributor.author	Adam de Beaumais, Tiphaine
dc.contributor.author	Marchais, Antonin
dc.contributor.author	Soriano Fernández, Aroa
dc.contributor.author	Hladun Alvaro, Raquel
dc.date.accessioned	2022-09-07T11:25:43Z
dc.date.available	2022-09-07T11:25:43Z
dc.date.issued	2022-05-01
dc.identifier.citation	Berlanga P, Pierron G, Lacroix L, Chicard M, Adam de Beaumais T, Marchais A, et al. The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies. Cancer Discov. 2022 May 1;12(5):1266–81.
dc.identifier.issn	2159-8290
dc.identifier.uri	https://hdl.handle.net/11351/8044
dc.description	Medicina de Precisión; Pacientes pediátricos y adolescentes; Neoplasias malignas recurrentes
dc.language.iso	eng
dc.publisher	American Association for Cancer Research
dc.relation.ispartofseries	Cancer Discovery;12(5)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Càncer - Recaiguda
dc.subject	Medicina personalitzada
dc.subject	Pediatria
dc.subject.mesh	Neoplasm Recurrence, Local
dc.subject.mesh	Precision Medicine
dc.subject.mesh	Neoplasms
dc.title	The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1158/2159-8290.CD-21-1136
dc.subject.decs	recurrencia neoplásica local
dc.subject.decs	medicina de precisión
dc.subject.decs	neoplasias
dc.relation.publishversion	https://doi.org/10.1158/2159-8290.CD-21-1136
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Berlanga P] Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [Pierron G] Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France. [Lacroix L] Department of Pathology and Laboratory Medicine, Translational Research Laboratory and Biobank, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [Chicard M] INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Research Center, PSL Research University, Institut Curie, Paris, France. [Adam de Beaumais T] Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [Marchais A] INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [Soriano Fernandez A] Grup de Recerca Translacional en Càncer en la Infància i l’Adolescència, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Hladun-Alvaro R] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid	35292802
dc.identifier.wos	000795663800001
dc.rights.accessrights	info:eu-repo/semantics/openAccess